BioNanoScience, Год журнала: 2025, Номер 15(2)
Опубликована: Март 13, 2025
Язык: Английский
BioNanoScience, Год журнала: 2025, Номер 15(2)
Опубликована: Март 13, 2025
Язык: Английский
Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown
Опубликована: Янв. 14, 2025
Язык: Английский
Процитировано
5Food Chemistry Advances, Год журнала: 2025, Номер 6, С. 100919 - 100919
Опубликована: Фев. 11, 2025
Язык: Английский
Процитировано
4Phytomedicine Plus, Год журнала: 2025, Номер unknown, С. 100754 - 100754
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
2Biomedicines, Год журнала: 2025, Номер 13(2), С. 422 - 422
Опубликована: Фев. 10, 2025
The intricate relationship between anticancer drugs and the gut microbiome influences cancer treatment outcomes. This review paper focuses on role of integrity in enhancing efficacy safety drug therapy, emphasizing pharmacokinetic interactions microbiota. It explores how disruptions to composition, or dysbiosis, can alter metabolism, immune responses, side effects. By examining mechanisms disruption caused by drugs, this highlights specific case studies like cyclophosphamide, 5-fluorouracil, irinotecan, their impact microbial diversity clinical also discusses microbiome-targeted strategies, including prebiotics, probiotics, postbiotics, fecal microbiota transplantation (FMT), as promising interventions enhance treatment. Furthermore, potential profiling personalizing therapy integrating these into practice is explored. Finally, proposes future research directions, developing novel biomarkers a deeper comprehension drug-microbiome interactions, respond current gaps knowledge improve patient outcomes care.
Язык: Английский
Процитировано
1Biomolecules, Год журнала: 2025, Номер 15(2), С. 270 - 270
Опубликована: Фев. 12, 2025
The gut-brain-cancer axis represents a novel and intricate connection between the gut microbiota, neurobiology, cancer progression. Recent advances have accentuated significant role of microbiota metabolites in modulating systemic processes that influence both brain health tumorigenesis. This paper explores emerging concept metabolite-mediated modulation within connection, focusing on key such as short-chain fatty acids (SCFAs), tryptophan derivatives, secondary bile acids, lipopolysaccharides (LPS). While microbiota's impact immune regulation, neuroinflammation, tumor development is well established, gaps remain grasping how specific contribute to neuro-cancer interactions. We discuss with potential implications for neurobiology cancer, indoles polyamines, which yet be extensively studied. Furthermore, we review preclinical clinical evidence linking dysbiosis, altered metabolite profiles, tumors, showcasing limitations research gaps, particularly human longitudinal studies. Case studies investigating microbiota-based interventions, including dietary changes, fecal transplantation, probiotics, demonstrate promise but also indicate hurdles translating these findings therapies. concludes call standardized multi-omics approaches bi-directional frameworks integrating microbiome, neuroscience, oncology develop personalized therapeutic strategies patients.
Язык: Английский
Процитировано
1Journal of Building Pathology and Rehabilitation, Год журнала: 2025, Номер 10(1)
Опубликована: Янв. 26, 2025
Язык: Английский
Процитировано
0Foods, Год журнала: 2025, Номер 14(4), С. 546 - 546
Опубликована: Фев. 7, 2025
This Editorial refers to the Special Issue "Further Research in Food Processing Safety and Quality from Field Fork", which addresses critical aspects of ensuring safety quality food throughout entire production chain [...].
Язык: Английский
Процитировано
0Hybrid Advances, Год журнала: 2025, Номер unknown, С. 100444 - 100444
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Food Engineering Reviews, Год журнала: 2025, Номер unknown
Опубликована: Март 25, 2025
Язык: Английский
Процитировано
0BioNanoScience, Год журнала: 2025, Номер 15(2)
Опубликована: Март 13, 2025
Язык: Английский
Процитировано
0